DR. DILLON & PARTNERS
SHANLIEVE SURGERY, SHANLIEVE SURGERY, KILKEEL PRIMARY CARE CENTRE, GREENCASTLE STREET, KILKEEL, NEWRY
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 7 | 8 | 87.5% | |
| HF 4 | 2011 | 12 | 12 | 100.0% | |
| HF 4 | 2012 | 18 | 22 | 81.8% | |
| HF 4 | 2013 | 19 | 23 | 82.6% | |
| HF004 | 2014 | 21 | 24 | 87.5% | |
| HF004 | 2015 | 21 | 26 | 80.8% | |
| HF004 | 2016 | 23 | 28 | 82.1% | |
| HF004 | 2017 | 18 | 23 | 78.3% | |
| HF004 | 2018 | 15 | 20 | 75.0% | |
| HF004 | 2019 | 12 | 16 | 75.0% | |
| HF004 | 2020 | 8 | 11 | 72.7% | |
| HF004 | 2021 | 9 | 12 | 75.0% |
